Literature DB >> 12464447

Homer 1a gene expression modulation by antipsychotic drugs: involvement of the glutamate metabotropic system and effects of D-cycloserine.

Daniela Polese1, Antonella Amato de Serpis, Alberto Ambesi-Impiombato, Giovanni Muscettola, Andrea de Bartolomeis.   

Abstract

N-methyl-D-aspartate receptor hypofunction has been suggested to play a role in the pathophysiology of schizophrenia. New glutamatergic mechanisms involving metabotropic receptors have been recently proposed to further expand this hypothesis. "Homer" is a family of postsynaptic density proteins functionally and physically attached to glutamate metabotropic receptors. We investigated the activation of the early gene form of Homer after acute treatment with typical or atypical antipsychotic drugs alone or with the adjunction of D-cycloserine. This activation was compared with that of c-fos, considered a putative molecular marker of brain regions activated by antipsychotics. Male Sprague-Dawley rats were treated intraperitoneally with haloperidol (0.8 mg/Kg) or clozapine (15 mg/Kg) alone or with the adjunction of D-cycloserine (20 mg/Kg). Rats were sacrificed ninety minutes after injection and the brains were processed for quantitative in situ hybridization histochemistry. Haloperidol induced a statistically significant increase of Homer both in caudate-putamen and nucleus accumbens compared with controls; clozapine induced Homer significantly only in the accumbens. The adjunction of D-cycloserine attenuated the haloperidol-induced increase of Homer expression in caudate-putamen and nucleus accumbens and attenuated the clozapine-induced increase in the accumbens. The c-fos gene expression was potently induced by haloperidol in caudate-putamen and nucleus accumbens, and by clozapine only in the accumbens. The adjunction of D-cycloserine enhanced c-fos expression only for clozapine in both regions of the forebrain. These results demonstrate a differential involvement of glutamatergic metabotropic system in gene expression modulation induced by typical or atypical antipsychotic drugs and may suggest new molecular basis for the augmentation strategy by a glycine site partial agonist.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12464447     DOI: 10.1016/S0893-133X(02)00371-8

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  22 in total

Review 1.  Homer/Vesl proteins and their roles in CNS neurons.

Authors:  Markus U Ehrengruber; Akihiko Kato; Kaoru Inokuchi; Sonia Hennou
Journal:  Mol Neurobiol       Date:  2004-06       Impact factor: 5.590

Review 2.  Glutamatergic postsynaptic density protein dysfunctions in synaptic plasticity and dendritic spines morphology: relevance to schizophrenia and other behavioral disorders pathophysiology, and implications for novel therapeutic approaches.

Authors:  Andrea de Bartolomeis; Gianmarco Latte; Carmine Tomasetti; Felice Iasevoli
Journal:  Mol Neurobiol       Date:  2013-09-03       Impact factor: 5.590

3.  Effect of the metabotropic glutamate antagonist MPEP on striatal expression of the Homer family proteins in levodopa-treated hemiparkinsonian rats.

Authors:  Anna Jiménez; Merce Bonastre; Esther Aguilar; Concepcio Marin
Journal:  Psychopharmacology (Berl)       Date:  2009-07-28       Impact factor: 4.530

Review 4.  Regulation of GPCR activity, trafficking and localization by GPCR-interacting proteins.

Authors:  Ana C Magalhaes; Henry Dunn; Stephen Sg Ferguson
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

Review 5.  Regulation and Function of Activity-Dependent Homer in Synaptic Plasticity.

Authors:  Nicholas E Clifton; Simon Trent; Kerrie L Thomas; Jeremy Hall
Journal:  Mol Neuropsychiatry       Date:  2019-05-23

6.  Genetic variability in scaffolding proteins and risk for schizophrenia and autism-spectrum disorders: a systematic review.

Authors:  Jordi Soler; Lourdes Fañanás; Mara Parellada; Marie-Odile Krebs; Guy A Rouleau; Mar Fatjó-Vilas
Journal:  J Psychiatry Neurosci       Date:  2018-05-28       Impact factor: 6.186

7.  Genetic variability in scaffolding proteins and risk for schizophrenia and autism-spectrum disorders: a systematic review.

Authors:  Jordi Soler; Lourdes Fañanás; Mara Parellada; Marie-Odile Krebs; Guy A Rouleau; Mar Fatjó-Vilas
Journal:  J Psychiatry Neurosci       Date:  2018-07       Impact factor: 6.186

8.  Chronic treatment with lithium or valproate modulates the expression of Homer1b/c and its related genes Shank and Inositol 1,4,5-trisphosphate receptor.

Authors:  Andrea de Bartolomeis; Carmine Tomasetti; Maria Cicale; Pei-Xiong Yuan; Husseini K Manji
Journal:  Eur Neuropsychopharmacol       Date:  2012-01-14       Impact factor: 4.600

9.  Molecular mechanisms of D-cycloserine in facilitating fear extinction: insights from RNAseq.

Authors:  Stefanie Malan-Müller; Lorren Fairbairn; Willie M U Daniels; Mahjoubeh Jalali Sefid Dashti; Edward J Oakeley; Marc Altorfer; Martin Kidd; Soraya Seedat; Junaid Gamieldien; Sîan Megan Joanna Hemmings
Journal:  Metab Brain Dis       Date:  2015-09-23       Impact factor: 3.584

10.  Divergent acute and chronic modulation of glutamatergic postsynaptic density genes expression by the antipsychotics haloperidol and sertindole.

Authors:  Felice Iasevoli; Carmine Tomasetti; Federica Marmo; Daniele Bravi; Jørn Arnt; Andrea de Bartolomeis
Journal:  Psychopharmacology (Berl)       Date:  2010-07-23       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.